PTPN3 and cholangiocarcinoma: Examples notably include the promotion of cholangiocarcinoma cell proliferation and migration by gain-of-function mutations or increased expression of the protein tyrosine phosphatase non-receptor type 3 (PTPN3) than in nontumor tissues (Gao et al., 2014).